You are here: Home » News-ANI » National
Business Standard

HLL introduces 'MakeSure' rapid diagnostic antibody kit for corona detection

Topics
Health Medical Pharma

ANI  |  General News 

HLL Lifecare Limited, a Central government enterprise under the Ministry of Health and Family Welfare, has developed the rapid antibody diagnostic kit for COVID-19.

"The kit is one-step novel coronavirus IgM/IgG antibody detection from the human serum, plasma and/or whole blood obtained from the patient with signs and symptoms of respiratory infection," said the HLL in a release.

The kit has been manufactured at HLL's rapid diagnostic kit manufacturing facility at Manesar and has been validated and approved by the NIV, Pune and the ICMR for use in India.

"This device is designed to aid in the rapid differential diagnosis of COVID-19 virus infection in large population screening in our country during the current pandemic situation and this shall support in the management of control and treatment of coronavirus disease," adds the release.

"The test result can be obtained from the patient sample within 15-20 minutes. HLL is the first Indian government company received the approval from the ICMR for manufacturing and supplying the rapid antibody kit for COVID-19 detection," the release further says.

The kit manufactured by HLL will be marketed under the brand name of "MakeSure" -- COVID IgM/IgG antibody detection.

The principle of 'MakeSure' COVID-19 IgM/IgG antibody test kit is based on antibody capture immunochromatographic assay for the simultaneous detection of IgM and IgG antibodies to COVID-19 virus in human serum, plasma and/or whole blood samples.

According to the release, HLL is planning to manufacture two lakh kits for supplying to various government units within the next 10 days.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, April 07 2020. 20:29 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU